T

Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM

Watchlist Manager
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Watchlist
Price: 3 202.65 INR 2.07% Market Closed
Market Cap: 1.1T INR
Have any thoughts about
Torrent Pharmaceuticals Ltd?
Write Note

Torrent Pharmaceuticals Ltd
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Torrent Pharmaceuticals Ltd
Depreciation & Amortization Peer Comparison

Comparables:
CIPLA
SUNPHARMA
ZYDUSLIFE
LUPIN
M
MANKIND

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Depreciation & Amortization
-â‚ą8.1B
CAGR 3-Years
-7%
CAGR 5-Years
-5%
CAGR 10-Years
-25%
Cipla Ltd
NSE:CIPLA
Depreciation & Amortization
-â‚ą10.6B
CAGR 3-Years
0%
CAGR 5-Years
5%
CAGR 10-Years
-10%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Depreciation & Amortization
-â‚ą25.6B
CAGR 3-Years
-7%
CAGR 5-Years
-7%
CAGR 10-Years
-17%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Depreciation & Amortization
-â‚ą8B
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
-14%
Lupin Ltd
NSE:LUPIN
Depreciation & Amortization
-â‚ą10.1B
CAGR 3-Years
-5%
CAGR 5-Years
-4%
CAGR 10-Years
-13%
M
Mankind Pharma Ltd
NSE:MANKIND
Depreciation & Amortization
-â‚ą4B
CAGR 3-Years
-50%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Torrent Pharmaceuticals Ltd's Depreciation & Amortization?
Depreciation & Amortization
-8.1B INR

Based on the financial report for Jun 30, 2024, Torrent Pharmaceuticals Ltd's Depreciation & Amortization amounts to -8.1B INR.

What is Torrent Pharmaceuticals Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
-25%

Over the last year, the Depreciation & Amortization growth was -10%. The average annual Depreciation & Amortization growth rates for Torrent Pharmaceuticals Ltd have been -7% over the past three years , -5% over the past five years , and -25% over the past ten years .

Back to Top